Loading grant details…
Enhancing and Evolving INFRAFRONTIER Disease Modelling Capacity to Enable Breakthrough Research
| Funder | European Commission |
|---|---|
| Recipient Organization | Infrafrontier Eric |
| Country | Germany |
| Start Date | Jun 01, 2024 |
| End Date | May 31, 2027 |
| Duration | 1,094 days |
| Number of Grantees | 18 |
| Roles | Participant; Coordinator; Associated Partner |
| Data Source | European Commission |
| Grant ID | 101131669 |
Grant Description
In response to the HORIZON-INFRA-2023-DEV-01-03 call, INFRAPLUS aims to expand INFRAFRONTIER's capacity for human disease modelling, refine its service portfolio by reducing animal usage and developing alternative cellular models, and optimise the use of resources.
INFRAPLUS seeks to achieve several objectives: Developing national node capacities and expertise for providing innovative in vivo, in vitro and preclinical services, developing novel model systems and services to meet the demands of existing and novel user communities, and reducing environmental impact.To achieve these objectives, INFRAPLUS will focus on launching pilot services, refining new technologies, emphasising alternate cellular models, designing and implementing special training programmes and optimising resources for the entire consortium.
The project includes a defined service development strategy supported by a strong IT and data management backbone and is built upon the needs of the scientific community.
Ultimately, INFRAPLUS will enhance and evolve INFRAFRONTIER's capacity for modelling human diseases and enable breakthrough research by providing researchers cutting-edge tools and services to respond to global biomedical challenges.
All Grantees
Oulun Yliopisto; Biomedcode Ellas Anonimi Eteria Epistimonikis Kai Texnologikis Erevnas Kai Emborikis Ekmetallefsis Epharmogon Iatrikis; Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh; Ustav Molekularni Genetiky Av Cr V.V.I.; Infrafrontier Eric; Fundacao Calouste Gulbenkian; Agencia Estatal Consejo Superior de Investigaciones Cientificas; Finnadvance Oy; United Kingdom Research and Innovation; Centre Europeen de Recherche En Biologie Et Medecine; Consiglio Nazionale Delle Ricerche; Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis; Veterinaermedizinische Universitaet Wien; Erevnitiko Kentro Vioiatrikon Epistimon Alexandros Flemingk; Karolinska Institutet; Universitat Autonoma de Barcelona; The Hospital for Sick Children; Centre National de la Recherche Scientifique CNRS
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Related Grants
